J. Goldman & Co’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,496
| Closed | -$327K | – | 344 |
|
|
2025
Q1 | $327K | Sell |
13,496
-4
| -0% | -$97 | 0.01% | 272 |
|
|
2024
Q4 | $282K | Hold |
13,500
| – | – | 0.01% | 285 |
|
|
2024
Q3 | $268K | Sell |
13,500
-6,750
| -33% | -$134K | 0.01% | 287 |
|
|
2024
Q2 | $314K | Sell |
20,250
-6,142
| -23% | -$95.1K | 0.01% | 271 |
|
|
2024
Q1 | $421K | Sell |
26,392
-349
| -1% | -$5.56K | 0.01% | 229 |
|
|
2023
Q4 | $450K | Buy |
26,741
+13,241
| +98% | +$223K | 0.02% | 173 |
|
|
2023
Q3 | $158K | Sell |
13,500
-513,202
| -97% | -$6M | 0.01% | 206 |
|
|
2023
Q2 | $7.08M | Buy |
526,702
+416,214
| +377% | +$5.59M | 0.26% | 76 |
|
|
2023
Q1 | $1.83M | Buy |
+110,488
| New | +$1.83M | 0.07% | 148 |
|
|
2020
Q3 | – | Sell |
-107,951
| Closed | -$499K | – | 233 |
|
|
2020
Q2 | $499K | Sell |
107,951
-346,822
| -76% | -$1.6M | 0.03% | 161 |
|
|
2020
Q1 | $1.75M | Buy |
+454,773
| New | +$1.75M | 0.21% | 85 |
|